price

NASDAQ · OCUL
Ocular Therapeutix, Inc.
Healthcare · Biotechnology
$10.49
Down-$0.13 (-1.22%)
Updated Sep 13, 2026, 11:06 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $7.38 – $11.74
- Volume
- 2.64M
- Avg. volume
- 3.15M
Price performance
OCUL price history
1M range · 19 trading sessions · Daily adjusted prices
OCUL closed at $10.49 after 19 trading sessions, down 1.50% for the selected period.
- Last close
- $10.49
- Period change
- -1.50%
- Period low
- $10.36
- Period high
- $11.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.75 | $10.94 | $10.365 | $10.49 | 2.64M |
| Sep 10, 2026 | $11.43 | $11.43 | $10.535 | $10.62 | 2.39M |
| Sep 9, 2026 | $11.24 | $11.48 | $11.02 | $11.47 | 2.8M |
| Sep 8, 2026 | $10.56 | $11.44 | $10.40 | $11.37 | 2.74M |
| Sep 4, 2026 | $10.51 | $10.77 | $10.51 | $10.64 | 1.31M |
| Sep 3, 2026 | $10.98 | $11.08 | $10.415 | $10.64 | 2.13M |
| Sep 2, 2026 | $10.58 | $11.01 | $10.47 | $10.90 | 2.07M |
| Sep 1, 2026 | $10.42 | $10.66 | $10.32 | $10.57 | 1.58M |
| Aug 31, 2026 | $10.30 | $10.535 | $10.13 | $10.49 | 1.52M |
| Aug 28, 2026 | $10.97 | $10.97 | $10.33 | $10.36 | 1.56M |
| Aug 27, 2026 | $10.63 | $10.955 | $10.57 | $10.82 | 1.43M |
| Aug 26, 2026 | $10.79 | $10.905 | $10.685 | $10.77 | 1.37M |
| Aug 25, 2026 | $10.98 | $11.17 | $10.87 | $10.88 | 1.84M |
| Aug 24, 2026 | $11.03 | $11.05 | $10.61 | $10.78 | 2.36M |
| Aug 21, 2026 | $11.10 | $11.49 | $10.935 | $11.08 | 3.05M |
| Aug 20, 2026 | $11.525 | $11.619 | $11.07 | $11.09 | 3.29M |
| Aug 19, 2026 | $11.29 | $11.74 | $11.185 | $11.73 | 3.02M |
| Aug 18, 2026 | $10.50 | $11.215 | $10.3015 | $11.01 | 4.58M |
| Aug 17, 2026 | $10.80 | $11.195 | $10.50 | $10.65 | 11.15M |
Latest OCUL news
The latest Smart Investors Daily articles mentioning OCUL.
Stock researchResearch & News · SID Coverage
Loading stock research…

